Literature DB >> 25260967

The cognition and emotional well-being indices of the Parkinson's disease questionnaire-39: what do they really measure?

Jacob D Jones1, Chris Hass2, Paul Mangal1, Jacob Lafo1, Michael S Okun3, Dawn Bowers4.   

Abstract

INTRODUCTION: The Parkinson's disease questionnaire-39 (PDQ-39) is a common measure of health related quality of life (HRQoL) that is widely used with Parkinson disease (PD) patients. Previous evidence suggests that the PDQ-39 reflects at least 8 dimensions (i.e., Emotion, Cognitions, Mobility, etc). To date, little research has examined the external/convergent validity of the Cognitions and Emotional Well-being domains of the PDQ-39.
METHODS: A convenience sample of 303 PD patients underwent a comprehensive multi-domain neuropsychological evaluation, including tests of execution function, episodic verbal memory, processing speed, language and working memory, as well as completing measures of depression, apathy, state and trait anxiety and HRQoL (PDQ-39). Hierarchical regressions were conducted in order to examine the relationship between scores on neuropsychological tests and the Cognitions index, as well as mood measures and the Emotional Well-being index of the PDQ-39.
RESULTS: Neuropsychological test performance did not account for a significant amount of variance in the PDQ-39 Cognitions index scores. Instead, it was depression that significantly contributed to the Cognitions index, above and beyond neuropsychological performance. The PDQ-39 Emotional Well-being index was also related to mood measures, primarily depression and trait anxiety.
CONCLUSIONS: The PDQ-39 Cognition index may be more related to mood functioning, as opposed to cognitive functioning, and should not be considered a "proxy" for cognitive functioning. Future studies are needed to better explain the construct of this index.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cognition; Depression; Health related quality of life; Parkinson's disease

Mesh:

Year:  2014        PMID: 25260967      PMCID: PMC4321103          DOI: 10.1016/j.parkreldis.2014.09.014

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  24 in total

1.  Factors affecting the quality of life of patients with idiopathic Parkinson's disease--a cross-sectional study in an outpatient clinic attendees.

Authors:  Jarosław Sławek; Mirosława Derejko; Piotr Lass
Journal:  Parkinsonism Relat Disord       Date:  2005-09-09       Impact factor: 4.891

Review 2.  Quality of life and depression in Parkinson's disease.

Authors:  Anette Schrag
Journal:  J Neurol Sci       Date:  2006-06-21       Impact factor: 3.181

3.  Is quality of life in non-demented Parkinson's disease patients related to cognitive performance? A clinic-based cross-sectional study.

Authors:  N Klepac; V Trkulja; M Relja; T Babić
Journal:  Eur J Neurol       Date:  2008-02       Impact factor: 6.089

4.  The validity of the Beck Depression Inventory as a screening and diagnostic instrument for depression in patients with Parkinson's disease.

Authors:  A F Leentjens; F R Verhey; G J Luijckx; J Troost
Journal:  Mov Disord       Date:  2000-11       Impact factor: 10.338

5.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

6.  Reliability, validity, and clinical correlates of apathy in Parkinson's disease.

Authors:  S E Starkstein; H S Mayberg; T J Preziosi; P Andrezejewski; R Leiguarda; R G Robinson
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1992       Impact factor: 2.198

7.  Apathy and anhedonia rating scales in Parkinson's disease: critique and recommendations.

Authors:  Albert F G Leentjens; Kathy Dujardin; Laura Marsh; Pablo Martinez-Martin; Irene H Richard; Sergio E Starkstein; Daniel Weintraub; Cristina Sampaio; Werner Poewe; Oliver Rascol; Glenn T Stebbins; Christopher G Goetz
Journal:  Mov Disord       Date:  2008-10-30       Impact factor: 10.338

8.  The 39 item Parkinson's disease questionnaire (PDQ-39) revisited: implications for evidence based medicine.

Authors:  Peter Hagell; Carita Nygren
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-04-18       Impact factor: 10.154

Review 9.  Quality of life and related concepts in Parkinson's disease: a systematic review.

Authors:  Brenda L Den Oudsten; Guus L Van Heck; Jolanda De Vries
Journal:  Mov Disord       Date:  2007-08-15       Impact factor: 10.338

10.  Validity and reliability of the PDQ-39 and the PDQ-8 in English-speaking Parkinson's disease patients in Singapore.

Authors:  Louis C S Tan; Nan Luo; Mohammed Nazri; Shu Chuen Li; Julian Thumboo
Journal:  Parkinsonism Relat Disord       Date:  2004-12       Impact factor: 4.891

View more
  16 in total

1.  Depressive symptoms precede cognitive impairment in de novo Parkinson's disease patients: Analysis of the PPMI cohort.

Authors:  Jacob D Jones; Natalie E Kurniadi; Taylor P Kuhn; Sarah M Szymkowicz; Joseph Bunch; Elizabeth Rahmani
Journal:  Neuropsychology       Date:  2019-07-25       Impact factor: 3.295

2.  Long-term Parkinson's disease quality of life after staged DBS: STN vs GPi and first vs second lead.

Authors:  Stephanie Cernera; Robert S Eisinger; Joshua K Wong; Kwo Wei David Ho; Janine Lobo Lopes; Kevin To; Samuel Carbunaru; Adolfo Ramirez-Zamora; Leonardo Almeida; Kelly D Foote; Michael S Okun; Aysegul Gunduz
Journal:  NPJ Parkinsons Dis       Date:  2020-07-06

3.  Impact of Mild Cognitive Impairment on Quality of Life in Young and Typical Onset Parkinson's Disease.

Authors:  Heather M Holden; Corrin N Schweer; Alexander I Tröster
Journal:  Mov Disord Clin Pract       Date:  2021-10-16

4.  What does the Dementia Rating Scale-2 measure? The relationship of neuropsychological measures to DRS-2 total and subscale scores in non-demented individuals with Parkinson's disease.

Authors:  Francesca V Lopez; Lauren E Kenney; Adrianna Ratajska; Charles E Jacobson; Dawn Bowers
Journal:  Clin Neuropsychol       Date:  2021-11-15       Impact factor: 4.373

5.  Sicca Symptoms in Parkinson's Disease: Association with Other Nonmotor Symptoms and Health-Related Quality of Life.

Authors:  Tino Prell; Denise Schaller; Caroline Perner; Otto W Witte; Julian Grosskreutz
Journal:  Parkinsons Dis       Date:  2020-02-12

6.  The effectiveness of specialized nursing interventions for patients with Parkinson disease: A randomized controlled study protocol.

Authors:  Yi Chen; Ting Lu; Xiaoyan Jiang; Xinyue Huang
Journal:  Medicine (Baltimore)       Date:  2021-01-15       Impact factor: 1.817

7.  Principal component-based weighted indices and a framework to evaluate indices: Results from the Medical Expenditure Panel Survey 1996 to 2011.

Authors:  Yi-Sheng Chao; Chao-Jung Wu
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240

8.  The impact of cognitive performance on quality of life in individuals with Parkinson's disease.

Authors:  Maira Rozenfeld Olchik; Annelise Ayres; Marcieli Ghisi; Artur Francisco Schumacher Schuh; Carlos Roberto Mello Rieder
Journal:  Dement Neuropsychol       Date:  2016 Oct-Dec

9.  Long-term Parkinson's disease quality of life after staged DBS: STN vs GPi and first vs second lead.

Authors:  Stephanie Cernera; Robert S Eisinger; Joshua K Wong; Kwo Wei David Ho; Janine Lobo Lopes; Kevin To; Samuel Carbunaru; Adolfo Ramirez-Zamora; Leonardo Almeida; Kelly D Foote; Michael S Okun; Aysegul Gunduz
Journal:  NPJ Parkinsons Dis       Date:  2020-07-06

10.  Emotional cues from expressive behavior of women and men with Parkinson's disease.

Authors:  Shu-Mei Wang; Linda Tickle-Degnen
Journal:  PLoS One       Date:  2018-07-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.